Codes / ICD10CM / C50.011

C50.011 Malignant neoplasm of nipple and areola, right female breast

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neoplasm of nipple and areola, right female breast
  • Breast cancer affecting the nipple and areolar region on the right side

Summary

Malignant neoplasm of the nipple and areola in the right female breast refers to cancerous growth in the nipple and surrounding areolar tissue. It is a specific subtype of breast cancer that may involve skin changes, discharge, or tissue abnormalities in this area. This condition requires clinical evaluation to confirm diagnosis and determine appropriate management.

Causes

The exact cause is not fully understood, but breast cancer generally arises from genetic mutations and cellular changes. Factors such as inherited gene mutations (e.g., BRCA1/BRCA2), hormonal influences, and environmental exposures may contribute to its development.

Risk Factors

  • Age (increased risk in older individuals)
  • Family history of breast cancer
  • Genetic predispositions (e.g., BRCA mutations)
  • Previous breast cancer diagnosis
  • Hormonal factors (e.g., early menstruation, late menopause)
  • Lifestyle factors (e.g., obesity, alcohol consumption)

Symptoms

  • Changes in nipple or areola appearance (e.g., scaling, redness)
  • Nipple discharge (especially bloody or clear fluid)
  • Nipple inversion or retraction
  • Persistent itching or pain in the nipple/areola area
  • Thickening or lump in the breast tissue near the nipple

Diagnosis

Diagnosis typically involves a combination of clinical examination, imaging studies (e.g., mammography, ultrasound), and tissue biopsy to confirm the presence of malignant cells. Pathological analysis of the biopsy sample is essential for definitive diagnosis.

Treatment Options

  • Surgery (lumpectomy or mastectomy) to remove the cancerous tissue
  • Radiation therapy to target and destroy cancer cells
  • Chemotherapy to kill cancer cells throughout the body or prevent their spread
  • Hormone therapy if the cancer is hormone receptor-positive
  • Targeted therapy for specific genetic mutations

Prognosis and Follow-Up

Prognosis depends on factors such as cancer stage, grade, and receptor status. Regular follow-up appointments, imaging, and clinical exams are necessary to monitor for recurrence or progression. Early detection and treatment improve outcomes.

Complications

  • Local spread to surrounding breast tissue
  • Lymph node involvement
  • Metastasis to distant organs (e.g., bones, lungs)
  • Treatment-related side effects (e.g., fatigue, lymphedema)

Lifestyle & Prevention

  • Maintain a healthy weight and balanced diet
  • Limit alcohol consumption
  • Engage in regular physical activity
  • Perform breast self-exams and attend routine screenings
  • Discuss risk-reducing strategies with a healthcare provider

When to Seek Professional Help

Seek medical attention if you notice persistent changes in the nipple or areola, unexplained discharge, or a lump. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Document the specific laterality (right) and anatomical site (nipple and areola) to ensure accurate coding. Verify clinical documentation supports the diagnosis and any associated procedures or treatments. Follow ICD-10-CM guidelines for coding malignant neoplasms of breast tissue.

Medical Policies and Guidelines

Related policies from health plans

BRCA Genetic Testing
Docetaxel (Docefrez, Taxotere)
Faslodex (fulvestrant)
Margenza (margetuximab-cmkb)
Halaven (eribulin)
Keytruda (pembrolizumab)
Ixempra (iIxabepilone)
Kadcyla (ado-trastuzumab)
Perjeta (pertuzumab)
Serum iron Testing
Tecentriq (atezolizumab)
CG-LAB-21 Serum Iron Testing
Book a walkthrough

C50.011 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.